Orli Schwartz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Orli Schwartz has a total of 175 co-authors. Here are the top co-authors by number of shared publications:
- Julian G. Simmons
Melbourne School of Psychological Sciences, The University of Melbourne, Melbourne, Victoria, Australia
39 shared publications - Nicholas B. Allen
Center for Digital Mental Health, University of Oregon, Eugene, Oregon, USA
32 shared publications - Sarah Whittle
Centre for Youth Mental Health, The University of Melbourne, Parkville, Australia
29 shared publications - Michelle L. Byrne
Department of Psychology, University of Oregon, Eugene, OR, USA
18 shared publications Lisa Sheeber
Oregon Research Institute, Eugene
12 shared publications- Marie Bee Hui Yap
Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Australia
11 shared publications
Latest Publications
- 27 November 2025
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 65 (11) , 1360-1372
Enhancing Emotion Regulation and Brain Connectivity in Adolescent Girls Through Parental Emotion Socialization: A Randomized Controlled Trial
- 27 November 2025
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 65 (11) , 1360-1372
Enhancing Emotion Regulation and Brain Connectivity in Adolescent Girls Through Parental Emotion Socialization: A Randomized Controlled Trial
- Open Access
- 24 October 2023
- Published by Springer Nature in Trials
- Vol. 24 (1) , 1-19
The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorder
Background: Existing treatments for young people with severe depression have limited effectiveness. The aim of the Study of Ketamine for Youth Depression (SKY-D) trial is to determine whether a 4-week course of low-dose subcutaneous ketamine is an effective adjunct to treatment-as-usual in young people with major depressive disorder (MDD). Methods: SKY-D is a double-masked, randomised controlled trial funded by the Australian Government’s National Health and Medical Research Council (NHMRC). Participants aged between 16 and 25 years (inclusive) with moderate-to-severe MDD will be randomised to receive either low-dose ketamine (intervention) or midazolam (active control) via subcutaneous injection once per week for 4 weeks. The primary outcome is change in depressive symptoms on the Montgomery-Åsberg Depression Rating Scale (MADRS) after 4 weeks of treatment. Further follow-up assessment will occur at 8 and 26 weeks from treatment commencement to determine whether treatment effects are sustained and to investigate safety outcomes. Discussion: Results from this trial will be important in determining whether low-dose subcutaneous ketamine is an effective treatment for young people with moderate-to-severe MDD. This will be the largest randomised trial to investigate the effects of ketamine to treat depression in young people. Trial registration: Australian and New Zealand Clinical Trials Registry ID: ACTRN12619000683134. Registered on May 7, 2019. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=377513.
- 24 October 2023
- Published by Springer Nature in Trials
- Vol. 24 (1) , 1-19
Open AccessThe Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorder
Background: Existing treatments for young people with severe depression have limited effectiveness. The aim of the Study of Ketamine for Youth Depression (SKY-D) trial is to determine whether a 4-week course of low-dose subcutaneous ketamine is an effective adjunct to treatment-as-usual in young people with major depressive disorder (MDD). Methods: SKY-D is a double-masked, randomised controlled trial funded by the Australian Government’s National Health and Medical Research Council (NHMRC). Participants aged between 16 and 25 years (inclusive) with moderate-to-severe MDD will be randomised to receive either low-dose ketamine (intervention) or midazolam (active control) via subcutaneous injection once per week for 4 weeks. The primary outcome is change in depressive symptoms on the Montgomery-Åsberg Depression Rating Scale (MADRS) after 4 weeks of treatment. Further follow-up assessment will occur at 8 and 26 weeks from treatment commencement to determine whether treatment effects are sustained and to investigate safety outcomes. Discussion: Results from this trial will be important in determining whether low-dose subcutaneous ketamine is an effective treatment for young people with moderate-to-severe MDD. This will be the largest randomised trial to investigate the effects of ketamine to treat depression in young people. Trial registration: Australian and New Zealand Clinical Trials Registry ID: ACTRN12619000683134. Registered on May 7, 2019. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=377513.
- Open Access
- 8 September 2023
- Published by Springer Nature in Research Square
The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorder
Background: Existing treatments for young people with severe depression have limited effectiveness. The aim of the Study of Ketamine for Youth Depression (SKY-D) trial is to determine whether a 4-week course of low-dose subcutaneous ketamine is an effective adjunct to treatment-as-usual in young people with major depressive disorder (MDD). Methods: SKY-D is a double-masked, randomised controlled trial funded by the Australian Government’s National Health and Medical Research Council (NHMRC). Participants aged between 16 to 25 years (inclusive) with moderate-to-severe MDD will be randomised to receive either low-dose ketamine (intervention) or midazolam (active control) via subcutaneous injection once per week for four weeks. The primary outcome is change in depressive symptoms on the Montgomery-Åsberg Depression Rating Scale (MADRS) after four weeks of treatment. Further follow-up assessment will occur at 8 and 26 weeks from treatment commencement to determine whether treatment effects are sustained and to investigate safety outcomes. Discussion: Results from this trial will be important in determining whether low-dose subcutaneous ketamine is an effective treatment for young people with moderate-to-severe MDD. This will be the largest randomised trial to investigate the effects of ketamine to treat depression in young people. Trial registration: Australian and New Zealand Clinical Trials Registry ID: ACTRN12619000683134. Registered on May 7, 2019. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=377513
- 8 September 2023
- Published by Springer Nature in Research Square
Open AccessThe Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorder
Background: Existing treatments for young people with severe depression have limited effectiveness. The aim of the Study of Ketamine for Youth Depression (SKY-D) trial is to determine whether a 4-week course of low-dose subcutaneous ketamine is an effective adjunct to treatment-as-usual in young people with major depressive disorder (MDD). Methods: SKY-D is a double-masked, randomised controlled trial funded by the Australian Government’s National Health and Medical Research Council (NHMRC). Participants aged between 16 to 25 years (inclusive) with moderate-to-severe MDD will be randomised to receive either low-dose ketamine (intervention) or midazolam (active control) via subcutaneous injection once per week for four weeks. The primary outcome is change in depressive symptoms on the Montgomery-Åsberg Depression Rating Scale (MADRS) after four weeks of treatment. Further follow-up assessment will occur at 8 and 26 weeks from treatment commencement to determine whether treatment effects are sustained and to investigate safety outcomes. Discussion: Results from this trial will be important in determining whether low-dose subcutaneous ketamine is an effective treatment for young people with moderate-to-severe MDD. This will be the largest randomised trial to investigate the effects of ketamine to treat depression in young people. Trial registration: Australian and New Zealand Clinical Trials Registry ID: ACTRN12619000683134. Registered on May 7, 2019. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=377513
- Open Access
- 3 November 2022
- Published by Wiley in Journal of Child Psychology and Psychiatry
- Vol. 64 (3) , 449-460
Development of morning–eveningness in adolescence: implications for brain development and psychopathology
Background: Morning–evening preference is defined as an individual's preference for a morning‐ or evening‐oriented rhythm. Across adolescence, a preference for eveningness becomes more predominant. Although eveningness is cross‐sectionally associated with internalizing and externalizing psychopathology, few studies have examined developmental changes in eveningness and its potential biological substrates. Here, we investigated the longitudinal relationships among the trajectory of eveningness preference, internalizing and externalizing psychopathology and white matter development, across adolescence. Methods: Two‐hundred and nine adolescents (49% male) were assessed longitudinally at four separate time points between 12 and 19 years of age. Morning–evening preference and internalizing and externalizing symptoms were assessed at each time point. Diffusion‐weighted images were acquired on a subset of participants at the final two time points to estimate changes in global mean fractional anisotropy (FA). Linear mixed models were performed to estimate the change in eveningness over time. A series of linear regression models assessed the influence of change in eveningness on psychopathology and white matter development at age 19. Results: Across the sample, a preference for eveningness became more predominant by 19 years of age. Greater individual‐level change towards eveningness significantly predicted greater severity in externalizing, but not internalizing, symptoms at 19 years of age. In contrast, change in psychopathology from 12 to 19 years of age was not associated with morning–eveningness at age 19. A change towards eveningness predicted an attenuated increase in FA between 17 and 19 years of age. Conclusions: This study suggests that developmental changes in morning–evening preference may predict both neurodevelopmental and psychological outcomes in adolescents.
- 3 November 2022
- Published by Wiley in Journal of Child Psychology and Psychiatry
- Vol. 64 (3) , 449-460
Open AccessDevelopment of morning–eveningness in adolescence: implications for brain development and psychopathology
Background: Morning–evening preference is defined as an individual's preference for a morning‐ or evening‐oriented rhythm. Across adolescence, a preference for eveningness becomes more predominant. Although eveningness is cross‐sectionally associated with internalizing and externalizing psychopathology, few studies have examined developmental changes in eveningness and its potential biological substrates. Here, we investigated the longitudinal relationships among the trajectory of eveningness preference, internalizing and externalizing psychopathology and white matter development, across adolescence. Methods: Two‐hundred and nine adolescents (49% male) were assessed longitudinally at four separate time points between 12 and 19 years of age. Morning–evening preference and internalizing and externalizing symptoms were assessed at each time point. Diffusion‐weighted images were acquired on a subset of participants at the final two time points to estimate changes in global mean fractional anisotropy (FA). Linear mixed models were performed to estimate the change in eveningness over time. A series of linear regression models assessed the influence of change in eveningness on psychopathology and white matter development at age 19. Results: Across the sample, a preference for eveningness became more predominant by 19 years of age. Greater individual‐level change towards eveningness significantly predicted greater severity in externalizing, but not internalizing, symptoms at 19 years of age. In contrast, change in psychopathology from 12 to 19 years of age was not associated with morning–eveningness at age 19. A change towards eveningness predicted an attenuated increase in FA between 17 and 19 years of age. Conclusions: This study suggests that developmental changes in morning–evening preference may predict both neurodevelopmental and psychological outcomes in adolescents.
- 1 April 2020
- Published by Elsevier in Journal of Affective Disorders
- Vol. 266, 429-446
Feeling down? A systematic review of the gut microbiota in anxiety/depression and irritable bowel syndrome
- 1 April 2020
- Published by Elsevier in Journal of Affective Disorders
- Vol. 266, 429-446
Feeling down? A systematic review of the gut microbiota in anxiety/depression and irritable bowel syndrome
- 1 February 2020
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 59 (2) , 274-282
The Influence of Maternal Parenting Style on the Neural Correlates of Emotion Processing in Children
- 1 February 2020
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 59 (2) , 274-282
The Influence of Maternal Parenting Style on the Neural Correlates of Emotion Processing in Children
- 1 August 2019
- Published by Elsevier in NeuroImage
- Vol. 197, 493-501
Interaction between hypothalamic-pituitary-adrenal axis genetic variation and maternal behavior in the prediction of amygdala connectivity in children
- 1 August 2019
- Published by Elsevier in NeuroImage
- Vol. 197, 493-501
Interaction between hypothalamic-pituitary-adrenal axis genetic variation and maternal behavior in the prediction of amygdala connectivity in children
- 1 May 2019
- Published by American Psychological Association (APA) in Psychology of Addictive Behaviors
- Vol. 33 (3) , 266-273
Early adolescent drinking and cannabis use predicts later sleep-quality problems.
A range of biopsychosocial changes occur during adolescence that contribute to changes in the sleep-wake system. Use of alcohol and cannabis also increases during early adolescence; however, limited studies have examined the associations between changes in the use of alcohol and cannabis and later sleep problems. Participants (n = 245) aged 12 years were recruited from schools and completed a baseline assessment, which included questions about their alcohol and cannabis use. Three subsequent follow-up assessments took place approximately 2.5 years (age 14 years), 4 years (age 16 years), and 6 years (age 18 years) after baseline, with sleep quality assessed at age 18 years. Earlier drug use was associated with poorer sleep quality at age 18 years, with different facets of alcohol and cannabis important in these associations. For alcohol, heavy episodic drinking across time was associated with poorer sleep; lifetime use at age 18 years (but not prior) was also associated with poorer sleep. For cannabis, recent use at age 18 years was associated with poor sleep quality. Our findings suggest that there are associations between specific facets of alcohol and cannabis use that are related to poor sleep in adolescents. (PsycINFO Database Record (c) 2019 APA, all rights reserved).
- 1 May 2019
- Published by American Psychological Association (APA) in Psychology of Addictive Behaviors
- Vol. 33 (3) , 266-273
Early adolescent drinking and cannabis use predicts later sleep-quality problems.
A range of biopsychosocial changes occur during adolescence that contribute to changes in the sleep-wake system. Use of alcohol and cannabis also increases during early adolescence; however, limited studies have examined the associations between changes in the use of alcohol and cannabis and later sleep problems. Participants (n = 245) aged 12 years were recruited from schools and completed a baseline assessment, which included questions about their alcohol and cannabis use. Three subsequent follow-up assessments took place approximately 2.5 years (age 14 years), 4 years (age 16 years), and 6 years (age 18 years) after baseline, with sleep quality assessed at age 18 years. Earlier drug use was associated with poorer sleep quality at age 18 years, with different facets of alcohol and cannabis important in these associations. For alcohol, heavy episodic drinking across time was associated with poorer sleep; lifetime use at age 18 years (but not prior) was also associated with poorer sleep. For cannabis, recent use at age 18 years was associated with poor sleep quality. Our findings suggest that there are associations between specific facets of alcohol and cannabis use that are related to poor sleep in adolescents. (PsycINFO Database Record (c) 2019 APA, all rights reserved).
- 21 February 2019
- Published by SAGE Publications in Assessment
- Vol. 27 (7) , 1547-1561
Factor Structure of the Early Adolescent Temperament Questionnaire–Revised
Early adolescence (typically aged 9-15 years) is a period of dramatic developmental change, and individual differences in temperament is likely to be an important predictor of the success with which individuals negotiate this period of life. Moreover, early adolescent temperament cannot be adequately captured by measures designed for other age groups. This study examined the empirical validity of the proposed temperament factors of the Early Adolescent Temperament Questionnaire–Revised (EATQ-R) in a large representative sample of 2,453 early adolescents aged between 10 and 12 years of age, and compared it with models that include cross-loadings between items and first-order factors, as well as first- and second-order factors. Furthermore, the reproducibility of the factor structure established by using a cross validation approach. Adding cross-loadings to the EATQ-R fit the data substantially better, resulting in an overall good fit that the original EATQ-R model did not achieve. However, the conceptual interpretation of the first- and second-order factor structures were not substantially altered even with this addition of cross-loadings. Future research should establish the construct validity of the first- and second-order factors as measured by this empirically based factor structure.
- 21 February 2019
- Published by SAGE Publications in Assessment
- Vol. 27 (7) , 1547-1561
Factor Structure of the Early Adolescent Temperament Questionnaire–Revised
Early adolescence (typically aged 9-15 years) is a period of dramatic developmental change, and individual differences in temperament is likely to be an important predictor of the success with which individuals negotiate this period of life. Moreover, early adolescent temperament cannot be adequately captured by measures designed for other age groups. This study examined the empirical validity of the proposed temperament factors of the Early Adolescent Temperament Questionnaire–Revised (EATQ-R) in a large representative sample of 2,453 early adolescents aged between 10 and 12 years of age, and compared it with models that include cross-loadings between items and first-order factors, as well as first- and second-order factors. Furthermore, the reproducibility of the factor structure established by using a cross validation approach. Adding cross-loadings to the EATQ-R fit the data substantially better, resulting in an overall good fit that the original EATQ-R model did not achieve. However, the conceptual interpretation of the first- and second-order factor structures were not substantially altered even with this addition of cross-loadings. Future research should establish the construct validity of the first- and second-order factors as measured by this empirically based factor structure.
- 4 February 2019
- Published by Cambridge University Press (CUP) in Development and Psychopathology
- Vol. 32 (1) , 139-150
Parenting × Brain Development interactions as predictors of adolescent depressive symptoms and well-being: Differential susceptibility or diathesis-stress?
It is unclear how individual differences in parenting and brain development interact to influence adolescent mental health outcomes. This study examined interactions between structural brain development and observed maternal parenting behavior in the prediction of adolescent depressive symptoms and psychological well-being. Whether findings supported diathesis-stress or differential susceptibility frameworks was tested. Participants completed observed interactions with their mothers during early adolescence (age 13), and the frequency of positive and aggressive maternal behavior were coded. Adolescents also completed structural magnetic resonance imaging scans at three time points: mean ages 13, 17, and 19. Regression models analyzed interactions between maternal behavior and longitudinal brain development in the prediction of late adolescent (age 19) outcomes. Indices designed to distinguish between diathesis-stress and differential susceptibility effects were employed. Results supported differential susceptibility: less thinning of frontal regions was associated with higher well-being in the context of low levels of aggressive maternal behavior, and lower well-being in the context of high levels of aggressive maternal behavior. Findings suggest that reduced frontal cortical thinning during adolescence may underlie increased sensitivity to maternal aggressive behavior for better and worse and highlight the importance of investigating biological vulnerability versus susceptibility.
- 4 February 2019
- Published by Cambridge University Press (CUP) in Development and Psychopathology
- Vol. 32 (1) , 139-150
Parenting × Brain Development interactions as predictors of adolescent depressive symptoms and well-being: Differential susceptibility or diathesis-stress?
It is unclear how individual differences in parenting and brain development interact to influence adolescent mental health outcomes. This study examined interactions between structural brain development and observed maternal parenting behavior in the prediction of adolescent depressive symptoms and psychological well-being. Whether findings supported diathesis-stress or differential susceptibility frameworks was tested. Participants completed observed interactions with their mothers during early adolescence (age 13), and the frequency of positive and aggressive maternal behavior were coded. Adolescents also completed structural magnetic resonance imaging scans at three time points: mean ages 13, 17, and 19. Regression models analyzed interactions between maternal behavior and longitudinal brain development in the prediction of late adolescent (age 19) outcomes. Indices designed to distinguish between diathesis-stress and differential susceptibility effects were employed. Results supported differential susceptibility: less thinning of frontal regions was associated with higher well-being in the context of low levels of aggressive maternal behavior, and lower well-being in the context of high levels of aggressive maternal behavior. Findings suggest that reduced frontal cortical thinning during adolescence may underlie increased sensitivity to maternal aggressive behavior for better and worse and highlight the importance of investigating biological vulnerability versus susceptibility.